President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.

Health-care companies fell amid fears of pharmaceutical drug-price controls. Novo Nordisk's Ozempic is "very likely" to be one the next drugs to have its price slashed in bargaining with the U.S.

More plaintiffs are continuing to join the diabetes drug Ozempic lawsuits against Novo Nordisk; and, until a couple of weeks ...

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...

--"It is very likely that Ozempic will be part of negotiations in the coming round, and we're ready for that," Ulrich Otte, senior vice president of finance & operations for Novo Nordisk, said Tuesday ...

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.

The ability to negotiate drug prices is part of a sweeping set of policies in President Joe Biden’s Inflation Reduction Act.

A recent study suggests that people taking the GLP-1 liraglutide experienced more bone loss than people who exercised during ...

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs to have its ...

U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they ...